News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acetylon Pharmaceuticals Celebrates Headquarters Expansion In Boston’s Innovation District


3/20/2014 10:09:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOSTON--(BUSINESS WIRE)--Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase (HDAC) inhibitors for enhanced therapeutic outcomes, today announced the expansion of its headquarters facility located in Boston’s Innovation District. Martin J. Walsh, Mayor of Boston, and Robert K. Coughlin, President and Chief Executive Officer of MassBio, are scheduled to join Acetylon employees and other invited guests this morning in a ribbon cutting ceremony at the Company.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES